More time spent in ideal cardiovascular health, starting as early as childhood, is associated not only with less subclinical atherosclerosis, but also with significant improvements in cardiometabolic health and a lower risk of all-cause mortality, according to the results of two new studies published this week in JAMA Cardiology.
In the first study, which was led by Vanessa Xanthakis, PhD (Boston University School of Medicine, MA), and Laura Corlin, PhD (Tufts University School of Medicine, Boston), longer durations of ideal or intermediate CV health in midlife were associated with lower risks of developing hypertension, diabetes, chronic kidney disease, CVD, and all-cause mortality when compared with men and women in poor CV health.
You dont have to be perfect, but the closer you are to a better overall lifestyle, the better off you are, Xanthakis told TCTMD.
Norrina Bai Allen, PhD (Northwestern University Feinberg School of Medicine, Chicago, IL), and colleagues took a different approach in their study but showed similar findings. In their analysis, they found that people who started in ideal CV health in childhood and stayed healthy throughout middle age had less subclinical atherosclerosis compared with those whose CV health declined rapidly after childhood or children who began with a less-than-ideal CV risk profile. To TCTMD, Allen said she and her team were surprised at how quickly CV health declined in
some of the young participants, noting that the early decliners had a downward progression that began much earlier than anticipated.
Its not just where you start, but its how fast you lose your cardiovascular health thats really important as well. Norrina Bai Allen
The rate at which you lose your cardiovascular health seems to play a particularly important role, she said. If you look at groups that started off at about the same level of CV health, those that declined more rapidly and earlier had a greater risk [for subclinical atherosclerosis] on carotid IMT [intima-media thickness]. So its not just where you start, but its how fast you lose your cardiovascular health thats really important as well.
In an editorial, Erica Spatz, MD (Yale School of Medicine, New Haven, CT), writes that both studies add to the growing recognition that assessing longitudinal cardiovascular health is critical for identifying populations at risk for future cardiovascular disease and informing primordial and primary prevention efforts. These papers, she says, show that from childhood through middle and even late adulthood, maintaining good cardiovascular health pays off.
Lifes Simple 7
In 2010, the American Heart Association created a CV health score based on Lifes Simple 7 that represents a summary burden of a persons CV risk factors and lifestyle metrics. The CV health score defines people as having ideal, intermediate, or poor CV health based on their blood pressure, glucose levels, weight, cholesterol levels, adherence to a healthy diet, physical activity levels, and smoking status. Studies have shown that very few US adultssomewhere in the range of 5% to 10%are in ideal CV health, and that percentage decreases further as people age.
While higher CV health scores have also been shown to be associated with a lower risk of diabetes, CVD, and all-cause mortality, little is known about the maintenance of CV health over longer periods of time.
To address this question, Xanthakis, Corlin, and colleagues identified 1,445 participants (mean age 60 years; 52% women) from the Framingham Offspring Study who attended examination cycles 5, 6, and 7 (1991-1995, 1995-1998, and 1998-2001, respectively) and compared outcomes of participants who spent 5 additional years in ideal or intermediate CV health versus those in poor CV health. Overall, the vast majority of the participants had poor or intermediate CV health, with just 7% of subjects in ideal CV health.
After adjusting for age and sex, each 5-year period that participants lived in ideal or intermediate CV health was associated with significantly better cardiometabolic measures, as well as a lower risk of all-cause mortality, when compared with those in poor CV health. In terms of secondary endpoints, each 5-year period spent in ideal/intermediate CV health was also associated with a significantly lower risk of coronary heart disease, stroke, congestive heart failure, and peripheral arterial disease.
Association of Intermediate/Ideal Versus Poor CV Health for 5 Years in Midlife
Outcome
Hazard Ratio (95% CI)
Hypertension
0.67 (0.56-0.80)
Diabetes
0.73 (0.57-0.93)
Chronic Kidney Disease
0.75 (0.63-0.89)
CVDa
0.73 (0.63-0.85)
All-Cause Mortality
0.86 (0.76-0.97)
aStroke, TIA, MI, coronary insufficiency, angina, intermittent claudication, or heart failure.
For example, with regards to physical activity, one of the components of Lifes Simple 7, people might be more active in the summer but hibernate in the winter, said Xanthakis. We decided to use 5-year increments so we could better capture lifestyle behavior. We want to emphasize that the longer you keep yourself in a healthy cardiovascular state, the lower your chance of getting diseased.
In terms of public health, Xanthakis said the implications could be great; quantifying these associations may help researchers understand that even small healthy changes in lifestyle maintained for a longer period could translate into years of a healthier life.
Every little healthier change matters, said Xanthakis, who also expressed gratitude to the Framingham Heart Study participants for dedicating their time so that the researchers could have such comprehensive data to evaluate their hypotheses.
Overall, she noted that Framingham is a relatively healthy cohort, which means that the beneficial effects of time spent in good CV health may be amplified among those with underlying health conditions. To facilitate changes at the community level, Xanthakis said every person should know their numbersweight, blood pressure, cholesterol levels, and glucose levelsso that they can focus on making the right improvements. Clinicians and public health professionals should also focus on educating the community on the importance of achieving those good numbers.
How Fast Does CV Health Decline and Does it Matter?
In the second study, Allen and colleagues sought to assess the longitudinal trajectories of CV health and the impact declines in CV health had on subclinical atherosclerosis. To do so, they turned to five prospective studies with childhood and young adulthood cohorts, including the Cardiovascular Risk in Young Finns Study (YFS), Bogalusa Heart Study (BHS), Project HeartBeat!, the Special Turku Coronary Risk Factor Intervention Project (STRIP), and the Coronary Artery Risk Development Study (CARDIA).
The researchers calculated a clinical CV health score based on measures of body mass index, blood pressure, blood glucose, and total cholesterol levels. They also performed a second analysis using the full Simple 7 metricsthe aforementioned clinical measures plus smoking status, diet, and physical activity levelsto create the full CV health score, but this was an exploratory analysis because participant data were only available at three or more examinations in YFS, CARDIA, and Project HeartBeat!.
In total, 1,518 participants had a high CV health score at 8 years of age that was maintained through early adulthood, while there were 2,403 and 3,066 participants with high CV health scores in childhood that experienced moderate or early declines in their CV health. For those with a moderate decline, the drop-off in CV health occurred around at 25 to 30 years while those with an early decline saw their CV health deteriorate in their teens or early 20s. The two remaining groups were roughly 2,500 subjects with intermediate CV health in childhood that declined early or later in life.
None of our groups were able to maintain ideal cardiovascular health throughout childhood and young adulthood, said Allen, a finding the group said wasnt surprising, although it was disheartening. We did find a significant proportion of children who maintained fairly high levels and then started to decline towards middle age. The most surprising finding to us was that already by age 8, which was the youngest age included in this cohort, there was a significant group of children, around 20%, who were no longer in ideal cardiovascular health.
Overall, the trajectory of the clinical CV health score was associated with continuous carotid IMT in adulthood. After adjusting for demographic and baseline smoking, physical activity, and diet, those with a high CV health score who declined later in life had the thinnest carotid IMT while those in intermediate CV health with an early decline had the thickest (0.64 vs 0.72mm, respectively; P < 0.001). In a comparison with the high CV score/late decline trajectory, those with the earliest declines in CV health, regardless of their CV health at baseline, were significantly more likely to have high carotid IMT levels. Similar results were observed when investigators calculated the CV health trajectory of subjects using all seven risk factors.
I think every year you can prevent poor levels of these risk factors is added benefit to reducing your risk of cardiovascular disease, but many of us strongly believe that protecting ideal levels is probably the most effective way to reduce cardiovascular risk or to eliminate it potentially, said Allen. One, you havent accumulated any subclinical damage due to elevated risk factors. Two, I also just think its easier to maintain a good behavior, like a healthy diet or physical activity, than it is to change once someone has started eating poorly or stopped exercising.
Spatz, in her editorial, notes that peoples willingness to make changes to their lifestyle depends on their perception of how vulnerable they might be. Young people, where death and disease are many years off, may be less likely to act on health issues within their control because the threats are less certain or more distant. However, these two new studies could provide an impetus for capturing peoples experiences and behaviors throughout the life span. In doing so, it may be possible to change their perceptions about prevention by incorporating cumulative cardiovascular health metrics and health trajectories.
Read the original post:
Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease - TCTMD
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com [Last Updated On: April 12th, 2018] [Originally Added On: April 12th, 2018]
- Cardiology | Weill Cornell Medicine [Last Updated On: April 14th, 2018] [Originally Added On: April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... [Last Updated On: May 15th, 2018] [Originally Added On: May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... [Last Updated On: May 16th, 2018] [Originally Added On: May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic [Last Updated On: May 27th, 2018] [Originally Added On: May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... [Last Updated On: June 23rd, 2018] [Originally Added On: June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- About Us - New Jersey Cardiology Associates [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- About Us - Ventura Clinical Trials [Last Updated On: August 16th, 2018] [Originally Added On: August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... [Last Updated On: August 22nd, 2018] [Originally Added On: August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology [Last Updated On: December 7th, 2018] [Originally Added On: December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... [Last Updated On: December 12th, 2018] [Originally Added On: December 12th, 2018]
- Clinical Cardiology - Baptist Health [Last Updated On: December 30th, 2018] [Originally Added On: December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology [Last Updated On: February 5th, 2019] [Originally Added On: February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine [Last Updated On: March 10th, 2019] [Originally Added On: March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]